Mesenchymal Stem/Stromal Cells: PRELIMINARY RESULTS FOR THE CELLULAR IMMUNO-THERAPY FOR COVID-19-RELATED ARDS MULTICENTRE CANADIAN RANDOMIZED CLINICAL TRIAL: CIRCA-19 PHASE 2 RCT
间充质干细胞/基质细胞:针对 COVID-19 相关 ARDS 的细胞免疫疗法加拿大多中心随机临床试验(CIRCA-19 II 期 RCT)的初步结果
期刊:EMBO Journal
影响因子:8.3
doi:10.1002/j.1460-2075.1984.tb02303.x
Revet, B; Zarling, D A; Jovin, T M; Delain, E; Stewart, DJ; English, S; Fergusson, D; Soliman, K; Chassé, M; Lalu, M; Thebaud, B; Watpool, I; Champagne, J; Courtman, DW; Khan, S; Hodgins, S